Ferroptosis and cardiovascular disease: role of free radical-induced lipid peroxidation

References

• Thomas H. et al.. Global atlas of cardiovascular disease 2000–2016: The path to prevention and control. Glob Heart. 2018;13(3):143–163.
   Google Scholar
• Vergallo R, Crea F. Atherosclerotic plaque healing. N Engl J Med. 2020;383(9):846–857.
   PubMed Web of Science ®Google Scholar
• Cannon B. Cardiovascular disease: biochemistry to behaviour. Nature. 2013;483:S2–S3.
   Google Scholar
• Liu J, Ma C. Current state of cardiovascular research in China. Nat Rev Cardiol. 2019;16(10):575–576.
   PubMed Web of Science ®Google Scholar
• Liu S, Li Y, Zeng X, et al. Burden of cardiovascular diseases in China, 1990–2016: findings from the 2016 global burden of disease study. JAMA Cardiol. 2019;4(4):342–352.
   PubMed Web of Science ®Google Scholar
• Yin H, Xu L, Porter NA. Free radical lipid peroxidation: mechanisms and analysis. Chem Rev. 2011;111(10):5944–5972.
   PubMed Web of Science ®Google Scholar
• Yin H, Porter NA. New insights regarding the autoxidation of polyunsaturated fatty acids. Antioxid Redox Signal. 2005;7(1–2):170–184.
   PubMed Web of Science ®Google Scholar
• Xiao M, Zhong H, Xia L, et al. Pathophysiology of mitochondrial lipid oxidation: Role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria. Free Radic Biol Med. 2017;111:316–327.
   PubMed Web of Science ®Google Scholar
• Zhong S, Li L, Shen X, et al. An update on lipid oxidation and inflammation in cardiovascular diseases. Free Radic Biol Med. 2019;144:266–278.
   PubMed Web of Science ®Google Scholar
• Guo S, Lu J, Zhuo Y, et al. Endogenous cholesterol ester hydroperoxides modulate cholesterol levels and inhibit cholesterol uptake in hepatocytes and macrophages. Redox Biol. 2019;21:101069.
   PubMed Web of Science ®Google Scholar
• Lu J, Guo S, Xue X, et al. Identification of a novel series of anti-inflammatory and anti-oxidative phospholipid oxidation products containing the cyclopentenone moiety in vitro and in vivo: Implication in atherosclerosis. J Biol Chem. 2017;292(13):5378–5391.
   PubMed Web of Science ®Google Scholar
• Berliner JA, Leitinger N, Tsimikas S. The role of oxidized phospholipids in atherosclerosis. J Lipid Res. 2009;50(Supplement):S207–S212.
   PubMedGoogle Scholar
• Lee S, Birukov KG, Romanoski CE, et al. Role of phospholipid oxidation products in atherosclerosis. Circ Res. 2012;111(6):778–799.
   PubMed Web of Science ®Google Scholar
• Berliner JA, Watson AD. A role for oxidized phospholipids in atherosclerosis. N Engl J Med. 2005;353(1):9–11.
   PubMed Web of Science ®Google Scholar
• Bayir H, Fadeel B, Palladino MJ, et al. Apoptotic interactions of cytochrome c: redox flirting with anionic phospholipids within and outside of mitochondria. Biochim Biophys Acta. 2006;1757(5–6):648–659. (2006).
   PubMed Web of Science ®Google Scholar
• Kagan VE, Tyurina YY, Bayir H, et al. The “pro-apoptotic genies” get out of mitochondria: oxidative lipidomics and redox activity of cytochrome c/cardiolipin complexes. Chem Biol Interact. 2006;163(1–2):15–28.
   PubMed Web of Science ®Google Scholar
• Tyurin VA, Tyurina YY, Osipov AN, et al. Interactions of cardiolipin and lyso-cardiolipins with cytochrome c and tBid: conflict or assistance in apoptosis. Cell Death Differ. 2007;14(4):872–875.
   PubMed Web of Science ®Google Scholar
• Tyurina YY, Shrivastava I, Tyurin VA, et al. “Only a life lived for others is worth living”: redox signaling by oxygenated phospholipids in cell fate decisions. Antioxid Redox Signal. 2018;29(13):1333–1358.
   PubMed Web of Science ®Google Scholar
• Greco D, Kotronen A, Westerbacka J, et al. Gene expression in human NAFLD. Am J Physiol Gastrointest Liver Physiol. 2008;294(5):G1281–G1287.
   PubMed Web of Science ®Google Scholar
• Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341–355.
   PubMed Web of Science ®Google Scholar
• Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell. 2001;104(4):503–516.
   PubMed Web of Science ®Google Scholar
• Zhong H, Lu J, Xia L, et al. Formation of electrophilic oxidation products from mitochondrial cardiolipin in vitro and in vivo in the context of apoptosis and atherosclerosis. Redox Biol. 2014;2:878–883.
   PubMed Web of Science ®Google Scholar
• Yurdagul A, Finney AC, Woolard MD, et al. The arterial microenvironment: the where and why of atherosclerosis. Biochem J. 2016;473(10):1281–1295.
   PubMedGoogle Scholar
• Tsimikas S, Karwatowska-Prokopczuk E, Gouni-Berthold I, et al. Lipoprotein(a) reduction in persons with cardiovascular disease. N Engl J Med. 2020;382(3):244–255. ).
   PubMed Web of Science ®Google Scholar
• Luo J, Yang H, Song B-L. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21(4):225–245.
   PubMed Web of Science ®Google Scholar
• Rosenson Robert S, Hegele Robert A, Koenig W. Cholesterol-lowering agents. Circ Res. 2019;124(3):364–385.
   PubMed Web of Science ®Google Scholar
• Yeang C, Wilkinson MJ, Tsimikas S. Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis. Curr Opin Cardiol. 2016;31(4):440–450.
   PubMed Web of Science ®Google Scholar
• Zheng KH, Tsimikas S, Pawade T, et al. Lipoprotein(a) and oxidized phospholipids promote valve calcification in patients with aortic stenosis. J Am Coll Cardiol. 2019;73(17):2150–2162.
   PubMed Web of Science ®Google Scholar
• Patel P, Karch J. Regulation of cell death in the cardiovascular system. Int Rev Cell Mol Biol. 2020;353:153–209.
   PubMed Web of Science ®Google Scholar
• Khan I, Yousif A, Chesnokov M, et al. A decade of cell death studies: breathing new life into necroptosis. Pharmacol Ther. 2020;107717.DOI:https://doi.org/10.1016/j.pharmthera.2020.107717
   Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072.
   PubMed Web of Science ®Google Scholar
• Wang H, Liu C, Zhao Y, et al. Mitochondria regulation in ferroptosis. Eur J Cell Biol. 2020;99(1):151058.
   PubMed Web of Science ®Google Scholar
• Conrad M, Pratt DA. The chemical basis of ferroptosis. Nat Chem Biol. 2019;15(12):1137–1147.
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Jiang X. The chemistry and biology of ferroptosis. Cell Chem Biol. 2020;27(4):365–375.
   PubMed Web of Science ®Google Scholar
• Han C, Liu Y, Dai R, et al. Ferroptosis and its potential role in human diseases. Front Pharmacol. 2020;11:239.
   PubMed Web of Science ®Google Scholar
• Yan B, Ai Y, Sun Q, et al. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol Cell. 2021;81:355–369.
   PubMed Web of Science ®Google Scholar
• Zou Y, Henry WS, Ricq EL, et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature. 2020;585(7826):603–608.
   PubMed Web of Science ®Google Scholar
• Anthonymuthu TS, Tyurina YY, Sun W-Y, et al. Resolving the paradox of ferroptotic cell death: Ferrostatin-1 binds to 15LOX/PEBP1 complex, suppresses generation of peroxidized ETE-PE, and protects against ferroptosis. Redox Biol. 2021;38:101744. doi:
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Winter GE, Musavi LS, et al. Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem Biol. 2015;10(7):1604–1609.
   PubMed Web of Science ®Google Scholar
• Yuan H, Li X, Zhang X, et al. Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem Biophys Res Commun. 2016;478(3):1338–1343.
   PubMed Web of Science ®Google Scholar
• Shah R, Shchepinov MS, Pratt DA. Resolving the role of lipoxygenases in the initiation and execution of ferroptosis. ACS Cent Sci. 2018;4(3):387–396.
   PubMed Web of Science ®Google Scholar
• Li M, He X, Guo W, et al. Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways. Nat Cancer. 2020;1(7):735–747.
   PubMedGoogle Scholar
• Li J, Cao F, Yin H-L, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88.
   PubMed Web of Science ®Google Scholar
• Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19(7):405–414.
   PubMed Web of Science ®Google Scholar
• Kagan VE, Tyurin VA, Jiang J, et al. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol. 2005;1(4):223–232.
   PubMed Web of Science ®Google Scholar
• Zhong H, Yin H. Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: Focusing on mitochondria. Redox Biol. 2015;4:193–199.
   PubMed Web of Science ®Google Scholar
• Yin, H, et al. Role of mitochondria in programmed cell death mediated by arachidonic acid-derived eicosanoids. Mitochondrion. 2013;13:209–224.
   PubMed Web of Science ®Google Scholar
• Gao M, Yi J, Zhu J, et al. Role of mitochondria in ferroptosis. Mol Cell. 2019;73(2):354–363.e3. 53,
   PubMed Web of Science ®Google Scholar
• Galaris D, Barbouti A, Pantopoulos K. Iron homeostasis and oxidative stress: an intimate relationship. Biochim Biophys Acta Mol Cell Res. 2019;1866(12):118535. doi:
   PubMed Web of Science ®Google Scholar
• Bayir H, et al. Achieving life through death: redox biology of lipid peroxidation in ferroptosis. Cell Chem Biol. 2020;27:387–408.
   PubMed Web of Science ®Google Scholar
• Green DR. The coming decade of cell death research: five riddles. Cell. 2019;177(5):1094–1107.
   PubMed Web of Science ®Google Scholar
• Kapralov AA, Yang Q, Dar HH, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat Chem Biol. 2020;16(3):278–290.
   PubMed Web of Science ®Google Scholar
• Haeggström JZ, Funk CD. Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem Rev. 2011;111(10):5866–5898.
   PubMed Web of Science ®Google Scholar
• Kagan VE, Mao G, Qu F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13(1):81–90.
   PubMed Web of Science ®Google Scholar
• Chu B, Kon N, Chen D, et al. ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway. Nat Cell Biol. 2019;21(5):579–591.
   PubMed Web of Science ®Google Scholar
• Wenzel SE, Tyurina YY, Zhao J, et al. PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals. Cell. 2017;171(3):628–641.e626.
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Jiang X, Gu W. Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol. 2020;30(6):478–490.
   PubMed Web of Science ®Google Scholar
• Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13(1):91–98.
   PubMed Web of Science ®Google Scholar
• Yagoda N, von Rechenberg M, Zaganjor E, et al. RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature. 2007;447(7146):865–869.
   Web of Science ®Google Scholar
• Wei X, Yin H. Covalent modification of DNA by α, β-unsaturated aldehydes derived from lipid peroxidation: Recent progress and challenges. Free Radic Res. 2015;49(7):905–917.
   PubMed Web of Science ®Google Scholar
• Zhong H, Xiao M, Zarkovic K, et al. Mitochondrial control of apoptosis through modulation of cardiolipin oxidation in hepatocellular carcinoma: a novel link between oxidative stress and cancer. Free Radic Biol Med. 2017;102:67–76.
   PubMed Web of Science ®Google Scholar
• Linkermann A, Skouta R, Himmerkus N, et al. Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci USA. 2014;111(47):16836–16841.
   PubMed Web of Science ®Google Scholar
• Li Y, Feng D, Wang Z, et al. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion. Cell Death Differ. 2019;26(11):2284–2299.
   PubMed Web of Science ®Google Scholar
• Sun X, Niu X, Chen R, et al. Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis. Hepatology. 2016;64(2):488–500.
   PubMed Web of Science ®Google Scholar
• Du Y, Bao J, Zhang M-J, et al. Targeting ferroptosis contributes to ATPR-induced AML differentiation via ROS-autophagy-lysosomal pathway. Gene. 2020;755:144889.
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang Q, Wang X, et al. Circular RNA cIARS regulates ferroptosis in HCC cells through interacting with RNA binding protein ALKBH5. Cell Death Discov. 2020;6:72.
   PubMed Web of Science ®Google Scholar
• Ma S, Dielschneider RF, Henson ES, et al. Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells. PLoS One. 2017;12(8):e0182921.
   PubMed Web of Science ®Google Scholar
• Tarangelo A, Dixon S. The p53-p21 pathway inhibits ferroptosis during metabolic stress. Oncotarget. 2018;9(37):24572–24573.
   PubMedGoogle Scholar
• Liu P, Wu D, Duan J, et al. NRF2 regulates the sensitivity of human NSCLC cells to cystine deprivation-induced ferroptosis via FOCAD-FAK signaling pathway. Redox Biol. 2020;37:101702.
   PubMed Web of Science ®Google Scholar
• Ravingerová T, Kindernay L, Barteková M, et al. The molecular mechanisms of iron metabolism and its role in cardiac dysfunction and cardioprotection. Int J Mol Sci. 2020;21:7889.
   PubMed Web of Science ®Google Scholar
• Whelan RS, Kaplinskiy V, Kitsis RN. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol. 2010;72:19–44.
   PubMed Web of Science ®Google Scholar
• Lee S-W, Won J-Y, Lee H-Y, et al. Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-β1/ERK/caspase-9 phosphorylation cascade. Mol Med. 2011;17(9–10):1095–1106.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Miriyala S, Miao L, et al. Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment. Free Radic Biol Med. 2014;72:55–65.
   PubMed Web of Science ®Google Scholar
• Gujja P, Rosing DR, Tripodi DJ, et al. Iron overload cardiomyopathy: better understanding of an increasing disorder. J Am Coll Cardiol. 2010;56(13):1001–1012.
   PubMed Web of Science ®Google Scholar
• Fang X, Wang H, Han D, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A. 2019;116(7):2672–2680.
   PubMed Web of Science ®Google Scholar
• Conrad M, Proneth B. Broken hearts: iron overload, ferroptosis and cardiomyopathy. Cell Res. 2019;29(4):263–264.
   PubMed Web of Science ®Google Scholar
• Fang X, Cai Z, Wang H, et al. Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis. Circ Res. 2020;127(4):486–501.
   PubMed Web of Science ®Google Scholar
• Zhong S, Li L, Zhang Y-L, et al. Acetaldehyde dehydrogenase 2 interactions with LDLR and AMPK regulate foam cell formation. J Clin Invest. 2019;129(1):252–267.
   PubMed Web of Science ®Google Scholar
• Tao W, Yurdagul A, Kong N et al. siRNA nanoparticles targeting CaMKIIgamma in lesional macrophages improve atherosclerotic plaque stability in mice. Sci Transl Med. 2020;12:eaay1063.
   PubMed Web of Science ®Google Scholar
• Willeit P, Tschiderer L, Allara E, et al. Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: meta-analysis of 119 clinical trials involving 100 667 patients. Circulation. 2020;142(7):621–642.
   PubMed Web of Science ®Google Scholar
• Bai T, Li M, Liu Y, et al. Inhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell. Free Radic Biol Med. 2020;160:92–102.
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu Y, Lan T, et al. Quantitative profiling of protein carbonylations in ferroptosis by an aniline-derived probe. J Am Chem Soc. 2018;140(13):4712–4720.
   PubMed Web of Science ®Google Scholar
• Dutta P, Courties G, Wei Y, et al. Myocardial infarction accelerates atherosclerosis. Nature. 2012;487(7407):325–329.
   PubMed Web of Science ®Google Scholar
• Chang M-K, Binder CJ, Miller YI, et al. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med. 2004;200(11):1359–1370. 10.1084/jem.20031763 [pii]
   PubMed Web of Science ®Google Scholar
• Hartvigsen K, Chou M-Y, Hansen LF, et al. The role of innate immunity in atherogenesis. J Lipid Res. 2009;50 Suppl:S388–S393. 10.1194/jlr.R800100-JLR200 [pii]
   PubMed Web of Science ®Google Scholar
• Miller YI, Choi S-H, Wiesner P, et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res. 2011;108(2):235–248.
   PubMed Web of Science ®Google Scholar
• Li W, Feng G, Gauthier JM, et al. Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation. J Clin Invest. 2019;129(6):2293–2304.
   PubMed Web of Science ®Google Scholar
• Li W, Li W, Leng Y, et al. Ferroptosis is involved in diabetes myocardial ischemia/reperfusion injury through endoplasmic reticulum stress. DNA Cell Biol. 2020;39(2):210–225.
   PubMed Web of Science ®Google Scholar
• Sempos CT, Looker AC, Gillum RF, et al. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II mortality study. Ann Epidemiol. 2000;10(7):441–448. doi:(00)00068-5
   PubMed Web of Science ®Google Scholar
• Liu J-R, Liu Y, Yin F-Z, et al. Serum ferritin, an early marker of cardiovascular risk: a study in Chinese men of first-degree relatives with family history of type 2 diabetes. BMC Cardiovasc Disord. 2019;19(1):82.
   PubMedGoogle Scholar
• Yin Z, Ding G, Chen X, et al. Beclin1 haploinsufficiency rescues low ambient temperature-induced cardiac remodeling and contractile dysfunction through inhibition of ferroptosis and mitochondrial injury. Metabolism. 2020;113:154397.
   PubMed Web of Science ®Google Scholar
• Esposito F, Ammendola R, Faraonio R, et al. Redox control of signal transduction, gene expression and cellular senescence. Neurochem Res. 2004;29:617–628.
   PubMed Web of Science ®Google Scholar
• Hirschhorn T, Stockwell BR. The development of the concept of ferroptosis. Free Radic Biol Med. 2019;133:130–143.
   PubMed Web of Science ®Google Scholar
• Jabs T. Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem Pharmacol. 1999;57:231–245.
   PubMed Web of Science ®Google Scholar
• Zou Y, Schreiber SL. Progress in understanding ferroptosis and challenges in its targeting for therapeutic benefit. Cell Chem Biol. 2020;27(4):463–471.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wei M, Liu G, et al. Silencing protease-activated receptor-2 alleviates ox-LDL-induced lipid accumulation, inflammation and apoptosis via activation of Wnt/β-catenin signaling . Gen Physiol Biophys. 2020;39(5):437–448.
   PubMed Web of Science ®Google Scholar
• Yin H, Gao L, Tai H-H, et al. Urinary prostaglandin F2a is generated from the isoprostane pathway and not the cyclooxygenase in humans. J Biol Chem. 2007;282(1):329–336.
   PubMed Web of Science ®Google Scholar
• Li L, Zhong S, Shen X, et al. Recent development on liquid chromatography-mass spectrometry analysis of oxidized lipids. Free Radic Biol Med. 2019;144:16–34. doi:
   PubMed Web of Science ®Google Scholar
• Yin H, Zhu M. Free radical oxidation of cardiolipin: chemical mechanisms, detection and implication in apoptosis, mitochondrial dysfunction and human diseases. Free Radic Res. 2012;46(8):959–974.
   PubMed Web of Science ®Google Scholar
• Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294(5548):1871–1875.
   PubMed Web of Science ®Google Scholar
• Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17:395–417.
   PubMed Web of Science ®Google Scholar
• Circu ML, Y, Aw T. Glutathione and apoptosis. Free Radic Res. 2008;42(8):689–706.
   PubMed Web of Science ®Google Scholar
• Kaminskyy VO, Zhivotovsky B. Free radicals in cross talk between autophagy and apoptosis. Antioxid Redox Signal. 2014;21(1):86–102.
   PubMed Web of Science ®Google Scholar
• Cherkas A, Zarkovic N. 4-Hydroxynonenal in redox homeostasis of gastrointestinal mucosa: implications for the stomach in health and diseases. Antioxidants. 2018;7:118.
   Web of Science ®Google Scholar
• Poli G, Zarkovic N. Editorial introduction to the special issue on 4-hydroxynonenal and related lipid oxidation products. Free Radic Biol Med. 2017;111:2–5.
   PubMed Web of Science ®Google Scholar
• Harden TK, Waldo GL, Hicks SN, et al. Mechanism of activation and inactivation of Gq/phospholipase C-β signaling nodes. Chem Rev. 2011;111(10):6120–6129.
   PubMed Web of Science ®Google Scholar
• Dennis EA, Cao J, Hsu Y-H, et al. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev. 2011;111(10):6130–6185.
   PubMed Web of Science ®Google Scholar
• Chen CH, Ferreira JCB, Mochly-Rosen D. ALDH2 and cardiovascular disease. Adv Exp Med Biol. 2019;1193:53–67.
   PubMed Web of Science ®Google Scholar
• Zhao J, You L, Wang DW, et al. Impacts of common variants in ALDH2 on coronary artery disease patients. Gene. 2016;585(1):104–109.
   PubMed Web of Science ®Google Scholar
• Lu X, Peloso GM, Liu DJ, et al. Exome chip meta-analysis identifies novel loci and East Asian-specific coding variants that contribute to lipid levels and coronary artery disease. Nat Genet. 2017;49(12):1722–1730.
   PubMed Web of Science ®Google Scholar
• Yang K, et al. Prevention of aortic dissection and aneurysm via an ALDH2-mediated switch in vascular smooth muscle cell phenotype. Eur Heart J. 2020;41:2442–2453.
   PubMed Web of Science ®Google Scholar